Kavita Dhodapkar MD
Associate Professor, Pediatrics, Yale University School of Medicine
Join to view full profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-520-5000
Dr. Dhodapkar is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Seth G.S. Medical CollegeClass of 1991
University of TennesseeFellowship, Pediatric Hematology/Oncology
Certifications & Licensure
WA State Medical License 2025 - 2028
GA State Medical License 2018 - 2027
CT State Medical License 2008 - 2018
NY State Medical License 1998 - 2011
AR State Medical License 1995 - 1999
MN State Medical License 1993 - 1996
Clinical Trials
- Rituximab and Hyaluronidase Human in Patients With Advanced Melanoma Undergoing Nivolumab and Ipilimumab Therapy Start of enrollment: 2019 Jun 05
Publications & Presentations
PubMed
- B cell depletion improves therapeutic index of combination checkpoint blockade in patients with advanced melanoma.Kavita M Dhodapkar, Antonio Matera, Alyssa M Duffy, Azmain Taz, Renee Julia Manalo
The Journal of Clinical Investigation. 2026-11-02 - 3 citationsHigh-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma.Emily Greene, Natalie K Horvat, Deon Bryant Doxie, Vaunita Cohen Parihar, Jayden Kim
Cancer Research. 2026-04-02 - 4 citationsFirst-in-child phase I trial of p-STAT3 inhibitor WP1066 in pediatric brain tumor patients.Robert C Castellino, Hope Mumme, Andrea Franson, Bing Yu, Hope Robinson
JCI Insight. 2026-02-09
Press Mentions
- Specific Components of the Tumor Immune Microenvironment May Affect the Durability of Responses to BCMA CAR T-cell TherapyAugust 29th, 2022
- Immune Cell Changes Detected in Waldenstrom Macroglobulinemia (WM)September 2nd, 2021
Unraveling How Immune Aging Influences Health Outcomes for Survivors of Childhood Blood CancersSeptember 2nd, 2026
Grant Support
- Immune aging and outcomes in adult survivors of childhood cancerFRED HUTCHINSON CANCER CENTER2026–2031
- Tumor and host immune signatures associated with patient outcomes to GD2 chemoimmunotherapy in neuroblastomaEMORY UNIVERSITY2024–2029
- B cells in autoimmunity following checkpoint blockadeFRED HUTCHINSON CANCER CENTER2019–2026
- B cell depletion to prevent autoimmunityEMORY UNIVERSITY2020–2025
- B cell depletion to prevent autoimmunityEMORY UNIVERSITY2020–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: